Extendicare Inc.
Extendicare Inc. Fundamental Analysis
Extendicare Inc. (EXETF) shows moderate financial fundamentals with a PE ratio of 23.98, profit margin of 5.82%, and ROE of 47.66%. The company generates $1.8B in annual revenue with strong year-over-year growth of 12.36%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 55.5/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze EXETF's fundamental strength across five key dimensions:
Efficiency Score
WeakEXETF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentEXETF trades at attractive valuation levels.
Growth Score
ModerateEXETF shows steady but slowing expansion.
Financial Health Score
ExcellentEXETF maintains a strong and stable balance sheet.
Profitability Score
ModerateEXETF maintains healthy but balanced margins.
Key Financial Metrics
Is EXETF Expensive or Cheap?
P/E Ratio
EXETF trades at 23.98 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, EXETF's PEG of -19.62 indicates potential undervaluation.
Price to Book
The market values Extendicare Inc. at 6.21 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 13.48 times EBITDA. This signals the market has high growth expectations.
How Well Does EXETF Make Money?
Net Profit Margin
For every $100 in sales, Extendicare Inc. keeps $5.82 as profit after all expenses.
Operating Margin
Core operations generate 8.35 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $47.66 in profit for every $100 of shareholder equity.
ROA
Extendicare Inc. generates $9.07 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Extendicare Inc. generates limited operating cash flow of $178.14M, signaling weaker underlying cash strength.
Free Cash Flow
Extendicare Inc. produces free cash flow of $68.92M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.73 in free cash annually.
FCF Yield
EXETF converts 2.58% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
23.98
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-19.62
vs 25 benchmark
P/B Ratio
Price to book value ratio
6.21
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.50
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.92
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.37
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.48
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.19
vs 25 benchmark
How EXETF Stacks Against Its Sector Peers
| Metric | EXETF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 23.98 | 27.91 | Better (Cheaper) |
| ROE | 47.66% | 687.00% | Weak |
| Net Margin | 5.82% | -45285.00% (disorted) | Weak |
| Debt/Equity | 0.92 | 0.33 | Weak (High Leverage) |
| Current Ratio | 1.37 | 2795.76 | Neutral |
| ROA | 9.07% | -13557.00% (disorted) | Weak |
EXETF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Extendicare Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
37.11%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
178.07%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
236.46%
Industry Style: Defensive, Growth, Innovation
High Growth